Pharmaceutical drug which emits radiation, used as a diagnostic or therapeutic agent
A carbon-11 labelled radiopharmaceutical Radiopharmaceuticals , or medicinal radiocompounds , are a group of pharmaceutical drugs containing radioactive isotopes . Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound. Radiopharmacology is the branch of pharmacology that specializes in these agents.
The main group of these compounds are the radiotracers used to diagnose dysfunction in body tissues . While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and still most common such drugs.
Drug nomenclature
As with other pharmaceutical drugs, there is standardization of the drug nomenclature for radiopharmaceuticals, although various standards coexist. The International Nonproprietary Names (INNs), United States Pharmacopeia (USP) names, and IUPAC names for these agents are usually similar other than trivial style differences.[ 1] The details are explained at Radiopharmacology § Drug nomenclature for radiopharmaceuticals .
Specific radiopharmaceuticals
A list of nuclear medicine radiopharmaceuticals follows. Some radioisotopes are used in ionic or inert form without attachment to a pharmaceutical; these are also included. There is a section for each radioisotope with a table of radiopharmaceuticals using that radioisotope. The sections are ordered alphabetically by the English name of the radioisotope. Sections for the same element are then ordered by atomic mass number .
Calcium-47
47 Ca is a beta and gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Ca-47-Ca2+
Bone metabolism
IV
In-vitro
Non-imaging
Carbon-11
11 C is a positron emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
C11-L-methyl-methionine
Brain tumour imaging
Parathyroid imaging
IV
In-vivo
Imaging
Carbon-14
14 C is a beta emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
C14-Glycocholic acid
Breath test for small intestine bacterial overgrowth
Oral
In-vitro
Non-imaging
C14-PABA (para-amino benzoic acid)
Pancreatic studies
Oral
In-vitro
Non-imaging
C14-Urea
Breath test to detect Helicobacter pylori
Oral
In-vitro
Non-imaging
C14-d-xylose
Breath test for small intestine bacterial overgrowth
Oral
In-vitro
Non-imaging
Chromium-51
51 Cr is a gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Cr51-[heart scan/blood volume
Red cell volume heart scan; sites of sequestration; gastrointestinal blood loss
IV
In-vitro
Non-imaging
Cr51-Cr3+
Gastrointestinal protein loss
IV
In-vitro
Non-imaging
Cr51-EDTA (ethylenediaminetetraacetic acid)
Glomerular filtration rate measurement
IV
In-vitro
Non-imaging
Cobalt-57
57 Co is a gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Co57-Cyanocobalamin (vitamin B12 )
Gastrointestinal absorption
Oral
In-vitro
Non-imaging
Cobalt-58
58 Co is a gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Co58-Cyanocobalamin (vitamin B12 )
Gastrointestinal absorption
Oral
In-vitro
Non-imaging
Erbium-169
169 Er is a beta emitter.
Name
Treatment of
Route of administration
Er169-Colloid
Arthritic conditions
Intra-articular
Fluorine-18
18 F is a positron emitter with a half-life of 109 minutes. It is produced in medical cyclotrons, usually from oxygen-18, and then chemically attached to a pharmaceutical. See PET scan .
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
F18-FDG (Fluorodeoxyglucose )
Tumor imaging
Myocardial imaging
IV
In-vivo
Imaging
F18-Sodium Fluoride
Bone imaging
IV
In-vivo
Imaging
F18-Fluorocholine
Prostate tumor imaging
IV
In-vivo
Imaging
F18-Desmethoxyfallypride
Dopamine receptor imaging
IV
In-vivo
Imaging
Gallium-67
67 Ga is a gamma emitter. See gallium scan .
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Ga67-Ga3+
Tumor imaging
IV
In-vivo
Imaging
Ga67-Ga3+
Infection/inflammation imaging
IV
In-vivo
Imaging
Gallium-68
68 Ga is a positron emitter, with a 68-minute half-life , produced by elution from germanium-68 in a gallium-68 generator or by proton irradiation of zinc-68. See also positron emission tomography .
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Ga68-Dotatoc or Dotatate
Neuroendocrine tumor imaging
IV
In-vivo
Imaging
Ga68-PSMA
Prostate cancer imaging
IV
In-vivo
Imaging
Hydrogen-3
3 H or tritium is a beta emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
H3-water
Total body water
Oral or IV
In-vitro
Non-imaging
Indium-111
111 In is a gamma emitter.
Iodine-123
Iodine-123 (I-123) is a gamma emitter. It is used only diagnostically, as its radiation is penetrating and short-lived.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
I123-Iodide
Thyroid uptake
Oral or IV
In-vivo
Non-imaging
I123-Iodide
Thyroid imaging
Thyroid metastases imaging
Oral or IV
In-vivo
Imaging
I123-o-Iodohippurate
Renal imaging
IV
In-vivo
Imaging
I123-MIBG (m-iodobenzylguanidine)
Neuroectodermal tumour imaging
IV
In-vivo
Imaging
I123-FP-CIT
SPECT imaging of Parkinson's Disease
IV
In-vivo
Imaging
Iodine-125
125 I is a gamma emitter with a long half-life of 59.4 days (the longest of all radioiodines used in medicine). Iodine-123 is preferred for imaging, so I-125 is used diagnostically only when the test requires a longer period to prepare the radiopharmaceutical and trace it, such as a fibrinogen scan to diagnose clotting. I-125's gamma radiation is of medium penetration, making it more useful as a therapeutic isotope for brachytherapy implant of radioisotope capsules for local treatment of cancers.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
I125-fibrinogen
Clot imaging
IV
In-vivo
Imaging
Iodine-131
131 I is a beta and gamma emitter. It is used both to destroy thyroid and thyroid cancer tissues (via beta radiation, which is short-range), and also other neuroendocrine tissues when used in MIBG. It can also be seen by a gamma camera , and can serve as a diagnostic imaging tracer, when treatment is also being attempted at the same time. However iodine-123 is usually preferred when only imaging is desired.
Diagnostic
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
I131-Iodide
Thyroid uptake
Oral
In-vivo
Non-imaging
I131-Iodide
Thyroid metastases imaging
Oral or IV
In-vivo
Imaging
I131-MIBG (m-iodobenzylguanidine)
Neuroectodermal tumor imaging
IV
In-vivo
Imaging
Therapeutic
Name
Treatment of
Route of administration
I131-Iodide
Thyrotoxicosis
IV or Oral
I131-Iodide
Non-toxic goiter
IV or Oral
I131-Iodide
Thyroid carcinoma
IV or Oral
I131-MIBG (m-iodobenzylguanidine)
Malignant disease
IV
Iron-59
59 Fe is a beta and gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Fe59-Fe2+ or Fe3+
Iron metabolism
IV
In-vitro
Non-imaging
Krypton-81m
81 Krm is a gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging the radioactive substance
Kr81m-Gas
Lung ventilation imaging
Inhalation
In-vivo
Imaging
Kr-81m-Aqueous solution
Lung perfusion imaging
IV
In-vivo
Imaging
Lutetium-177
177 Lu is a beta emitter.
Nitrogen-13
13 N is a positron emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
N13-Ammonia
Myocardial blood flow imaging
IV
In-vivo
Imaging
Oxygen-15
15 O is a positron emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
O15-Water
Cerebral blood flow imaging
Myocardial blood flow imaging
IV bolus
In-vivo
Imaging
Phosphorus-32
32 P is a beta emitter.
Name
Treatment of
Route of administration
P32-Phosphate
Polycythemia and related disorders
IV or Oral
Radium-223
223 Ra is an alpha emitter.
Rubidium-82
82 Rb is a positron and gamma emitter.
Name
Investigation of
Route of administration
Rb-82 chloride
Myocardial Imaging
IV
Samarium-153
153 Sm is a beta and gamma emitter.
Name
Treatment of
Route of administration
Sm153-EDTMP (Ethylenediaminotetramethylenephosphoric acid)
Bone metastases
IV
Selenium-75
75 Se is a gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Se75-Selenorcholesterol
Adrenal gland imaging
IV
In-vivo
Imaging
Se75-SeHCAT (23-Seleno-25-homo-tauro-cholate)
Bile salt absorption
Oral
In-vivo
Imaging
Sodium-22
22 Na is a positron and gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Na22-Na+
Electrolyte studies
Oral or IV
In-vitro
Non-imaging
Sodium-24
24 Na is a beta and gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Na24-Na+
Electrolyte studies
Oral or IV
In-vitro
Non-imaging
Strontium-89
89 Sr is a beta emitter.
Name
Treatment of
Route of administration
Sr89-Chloride
Bone metastases
IV
Technetium-99m
Technetium-99m is a gamma emitter. It is obtained on-site at the imaging center as the soluble pertechnetate which is eluted from a technetium-99m generator , and then either used directly as this soluble salt, or else used to synthesize a number of technetium-99m-based radiopharmaceuticals.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Tc99m-pertechnetate
Thyroid uptake and thyroid imaging
Stomach and salivary gland imaging
Meckel's diverticulum imaging
Brain imaging
Micturating cystogram
First pass blood flow imaging
First pass peripheral vascular imaging
IV
In-vivo
Imaging
Tc99m-pertechnetate
Lacrimal imaging
Eye drops
In-vivo
Imaging
Tc99m-Human albumin
Cardiac blood pool imaging
IV
In-vivo
Imaging
Tc99m-Human albumin
Peripheral vascular imaging
IV
In-vivo
Imaging
Tc99m-Human albumin macroaggregates or microspheres
Lung perfusion imaging
IV
In-vivo
Imaging
Tc99m-Human albumin macroaggregates or microspheres
Lung perfusion imaging with venography
IV
In-vivo
Imaging
Tc99m-Phosphonates and phosphates (MDP/HDP)
Bone imaging
IV
In-vivo
Imaging
Tc99m-Phosphonates and phosphates
Myocardial imaging
IV
In-vivo
Imaging
Tc99m-DTPA (diethylenetriaminepenta-acetic acid)
Renal imaging First pass blood flow studies Brain imaging
IV
In-vivo
Imaging
Tc99m-DTPA (diethylenetriaminepenta-acetic acid)
Lung ventilation imaging
Aerosol inhalation
In-vivo
Imaging
Tc99m-DMSA(V) (dimercaptosuccinic acid )
Tumor imaging
IV
In-vivo
Imaging
Tc99m-DMSA(III) (dimercaptosuccinic acid )
Renal imaging
IV
In-vivo
Imaging
Tc99m-Colloid
Bone marrow imaging
GI Bleeding
IV
In-vivo
Imaging
Tc99m-Colloid
Lymph node imaging
Interstitial
In-vivo
Imaging
Tc99m-Colloid
Esophageal transit and reflux imaging
Gastric emptying imaging
Oral
In-vivo
Imaging
Tc99m-Colloid
Lacrimal imaging
Eye drops
In-vivo
Imaging
Tc99m-HIDA (Hepatic iminodiacetic acid)
Functional biliary system imaging
IV
In-vivo
Imaging
Tc99m-Denatured (heat damaged) red blood cells
Red cell volume
Spleen imaging
IV
In-vitro
Non-imaging
Tc99m-Whole red blood cells
GI bleeding
Cardiac blood pool imaging
Peripheral vascular imaging
IV
In-vivo
Imaging
Tc99m-MAG3 (mercaptoacetyltriglycine)
Renal imaging
First pass blood flow imaging
IV
In-vivo
Imaging
Tc99m-Exametazime (HMPAO)
Cerebral blood flow imaging
IV
In-vivo
Imaging
Tc99m-Exametazime labelled leucocytes
Infection/inflammation imaging
IV
In-vivo
Imaging
Tc99m-Sestamibi (MIBI - methoxy isobutyl isonitrile)
Parathyroid imaging
Non-specific tumor imaging
Thyroid tumor imaging
Breast imaging
Myocardial imaging
IV
In-vivo
Imaging
Tc99m-Sulesomab (IMMU-MN3 murine Fab'-SH antigranulocyte monoclonal antibody fragments)
Infection/inflammation imaging
IV
In-vivo
Imaging
Tc99m-Technegas
Lung ventilation imaging
Inhalation
In-vivo
Imaging
Tc99m-Human immunoglobulin
Infection/inflammation imaging
IV
In-vivo
Imaging
Tc99m-Tetrofosmin
Parathyroid imaging
Myocardial imaging
IV
In-vivo
Imaging
Tc99m-ECD (ethyl cysteinate dimer)
Brain imaging-----
IV
In-vivo
Imaging
Thallium-201
201 Tl is a gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Tl201-Tl+
Non-specific tumor imaging
Thyroid tumor imaging
Myocardial imaging
Parathyroid imaging
IV
In-vivo
Imaging
Xenon-133
133 Xe is a gamma emitter.
Name
Investigation
Route of administration
In-vitro / in-vivo
Imaging / non-imaging
Xe133-gas
Lung ventilation studies
Inhalation
In-vivo
Imaging
Xe133 in isotonic sodium chloride solution
Cerebral blood flow
IV
In-vivo
Imaging
Yttrium-90
90 Y is a beta emitter.
Name
Treatment of
Route of administration
Y90-Silicate
Arthritic conditions
Intra-articular
Y90-Silicate
Malignant disease
Intracavitary
See also
References
External links